This integrative literature review is focused on (1) the prevalence of bone mineral density (BMD) decrements in children treated for acute lymphoblastic leukemia (ALL), and when these decrements are observed; (2) the risk factors associated with the development of decreased BMD and resultant complications in children treated for ALL; (3) the role, if any, that corticosteroids play in decreasing BMD in children treated for ALL; (4) interventions that can potentially manage bone loss in people treated for ALL during childhood or adolescence. The results showed that people who have been diagnosed with ALL can have decrements in BMD. The etiology of BMD decrements can be attributed to multiple factors including genetic endowment, lifestyle behaviors, the leukemia disease process, and treatment exposures especially to corticosteroids and cranial radiotherapy. Male gender, age greater than 10 years, and physical inactivity are associated with BMD decrements in ALL survivors. The role of pediatric oncology nurses in the management of bone disease in children with cancer across the illness trajectory is discussed.
Aisenberg, J., Hseih, K., Kalaitzoglou, G., Whittam, E., Heller, G., Schneider, R., et al. (1998). BMD in young adult survivors of childhood cancer. Journal of Pediatric Hematology and Oncology, 20, 241-245.
2.
Allgrove, J. (1997). Bisphosphonates. Archives of Disease in Childhood, 76, 73-75.
3.
Arikoski, P., Komulainen, J., Riikonen, P., Jurvelin, J. S., Voutilainen, R., & Kroger, H. (1999). Reduced bone density at completion of chemotherapy for a malignancy. Archives of Disease in Childhood, 80, 143-148.
4.
Arikoski, P., Komulainen, J., Voutilainen, R., Riikonen, P., Parviainen, M., Tapanainen, P., et al. (1998). Reduced BMD in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology and Oncology, 20, 234-240.
5.
Atkinson, S. A., Halton, J. M., Bradley, C., Wu, B., & Barr, R. D. (1998). Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition. International Journal of Cancer, 11S, 35-39.
6.
Bachrach, L. K. (2001). Acquisition of optimal bone mass in childhood and adolescence. Trends in Endocrinology &Metabolism, 12, 22-28.
7.
Chan, Y., & Bishop, N. (2002). Clinical management of childhood osteoporosis. International Journal of Clinical Practice, 56, 280-286.
8.
Children’s Oncology Group. (2004, March). Keeping your bones healthy after childhood cancer. Health Link. Retrieved May 1, 2004, from http://www.survivorshipguidelines.org/pdf/Bone-Health.pdf
9.
Clowes, J. A., Peel, N., & Eastell, R. (2001). Glucocorticoid-induced osteoporosis. Current Opinion in Rheumatology, 13, 326-332.
10.
Crist, W., & Smithson, W. (2000). The leukemias. In R. E. Behrman, R. M. Kliegman, & H. B. Jenson (Eds.), Nelson textbook of pediatrics (16th ed., pp. 1543-1546). Philadelphia: W. B. Saunders.
11.
DiPaola, R. S., Reiss, M., & Aisner, J. (2001). Hormones. In M. C. Perry (Ed.), The chemotherapy source book (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. Retrieved February 10, 2003, from http://www.med.yale.edu/library/nursing/books/ebooks
12.
Erickson, J. (2004). Fatigue in adolescents with cancer: A review of the literature. Clinical Journal of Oncology Nursing, 8, 139-145.
13.
Ferretti, J. L., Capozza, R. F., Cointry, G. R., Garcia, S. L., Plotkin, H., Alvarez-Filgueira, M. L., et al. (1998). Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone, 22, 683-690.
14.
Fischer, D. S., Knobf, M. T., Durivage, H. J., & Beaulieu, N. (2003). The cancer chemotherapy handbook (6th ed.). St. Louis, MO: Mosby.
15.
Ganong, L H. (1987). Integrative reviews of nursing research. Research in Nursing and Health, 10, 1-11.
16.
Garrard, J. (1999). Health sciences literature review made easy: The matrix method. Gaithersburg, MD: Aspen.
17.
Gleeson, H. K., & Shalet, S. M. (2001). Endocrine complications of neoplastic diseases in children and adolescents. Current Opinion in Pediatrics, 13, 346-351.
18.
Gordon, C. M. (2003). Normal bone accretion and effects of nutritional disorders in childhood. Journal of Women’s Health, 12, 137-143.
19.
Halton, J. M., Atkinson, S. A., Fraher, L., Webber, C. E., Cockshott, W. P, Tam, C. et al. (1995). Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. Journal of Pediatrics, 126, 557-564.
20.
Henderson, R. C., Madsen, C. D., Davis, C., & Gold, S. H. (1998). Longitudinal evaluation of BMD in children receiving chemotherapy. Journal of Pediatric Hematology & Oncology, 20, 322-326.
21.
Hergenroeder, A., & Chorley, J. (2000). Female athletes, menstrual problems, and the risk for osteopenia. In R. E. Behrman, R. M. Kliegman, & H. B. Jenson (Eds.), Nelson textbook of pediatrics (16th ed., p. 2109). Philadelphia: W. B. Saunders.
22.
Johnston, C. C., Miller, J. Z., Slemenda, C. W., Reister, T. K., Hui, S., Christian, J. C., et al. (1992). Calcium supplementation and increases in BMD in children. New England Journal of Medicine, 327, 82-87.
23.
Kadan-Lottick, N., Marshall, J. A., Baron, A. E., Krebs, N. F., Hambidge, H. M., & Albano, E. (2001). Normal BMD after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. Journal of Pediatrics, 138, 898-904.
24.
Kaste, S. C., Jones-Wallace, D., Rose, S. R., Boyett, J. M., Lustig, R. H., Rivera, G. K., et al. (2001). Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia, 15, 728-734.
25.
Lee, W. T., Leung, S. S., Wang, S. H., Xu, Y., Zeng, W., Lau, J., et al. (1994). Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. American Journal of Clinical Nutrition, 60, 744-750.
26.
Leonard, M. B., & Zemel, B. S. (2002). Current concepts in bone disease. Pediatric Clinics of North America, 49, 143-173.
27.
Mandel, K., Atkinson, S., Barr, R. D., & Pencharz, P. (2004). Skeletal morbidity in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 22, 1215-1221.
28.
Mock, V., Pickett, M., Ropka, M. E., Muscari, L. E., Stewart, K. J., Rhodes, V. A., et al. (2001). Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Practice, 9, 119-127.
29.
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. (2001). Osteoporosis prevention, diagnosis and therapy. Journal of the American Medical Association, 285, 785-795.
30.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001). Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone, 29, 498-505.
31.
Reginster, J. Y., Halkin, V., Henrotin, Y., & Gosset, C. (1999). Treatment of osteoporosis: Role of bone-forming agents. Osteoporosis International, Suppl., 2, 91-96.
32.
Reid, I. R. (1999). Glucocorticoid osteoporosis. Journal of Intensive Care Medicine, 14, 231-242.
33.
Saggese, G., Baroncelli, G. I., & Bertelloni, S. (2001). Osteoporosis in children and adolescents: Diagnosis, risk factors and prevention. Journal of Pediatric Endocrinology & Metabolism, 14, 833-859.
34.
Soyka, L. A., Fairfield, W. P., & Klibanski, A. (2000). Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. Journal of Clinical Endocrinology & Metabolism, 85, 3951-3963.
35.
Tillmann, V., Darlington, A., Eiser, C., Bishop, N., & Davies, H. (2002). Male sex and low physical activity are associated with reduced BMD in survivors of childhood acute lymphoblastic leukemia. Journal of Bone and Mineral Research, 17, 1073-1080.
36.
Van der Sluis, I., van den Heuvel-Eibrink, M., Hahlen, K., Krenning, E., & de Muinck Keizer-Schrama, S. (2002). Altered BMD and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. Journal of Pediatrics, 141, 204-210.
37.
Vassilipoulou-Sellin, R., Brosnan, P., Delpassand, A., Zeitz, H., Klein, M. J., & Jaffe, N. (1999). Osteopenia in young adult survivors of childhood cancer. Medical and Pediatric Oncology, 32, 272-278.
38.
Warner, J., Evans, W. D., David, K., Bell, W., & Gregory, J. (1999). Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatric Research, 45, 544-551.
